Barclays PLC Adagene Inc. Transaction History
Barclays PLC
- $353 Billion
- Q1 2025
A detailed history of Barclays PLC transactions in Adagene Inc. stock. As of the latest transaction made, Barclays PLC holds 122,516 shares of ADAG stock, worth $215,628. This represents 0.0% of its overall portfolio holdings.
Number of Shares
122,516
Previous 186,903
34.45%
Holding current value
$215,628
Previous $372,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ADAG
# of Institutions
13Shares Held
10.4MCall Options Held
0Put Options Held
0-
Wu Xi App Tec Co., Ltd. Shanghai, F43.98MShares$7.01 Million46.44% of portfolio
-
General Atlantic LLC New York, NY3.83MShares$6.73 Million0.2% of portfolio
-
Sc China Holding LTD N/A, K31.34MShares$2.36 Million0.11% of portfolio
-
Fil LTD Hamilton, D0749KShares$1.32 Million0.0% of portfolio
-
Mill Creek Capital Advisors, LLC Conshohocken, PA200KShares$351,3130.01% of portfolio
About Adagene Inc.
- Ticker ADAG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,423,200
- Market Cap $76.4M
- Description
- Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid ...